Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients [Phase 1, Phase 2]
This is a Phase 1/2 dose-ranging study of lenalidomide in patients with non-5q deletion myelodysplastic syndrome (low- to intermediate-1 ris…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants [Phase 1]
Phase 1 trial evaluating total body irradiation with fludarabine followed by combined umbilical cord blood transplants has completed. The tr…
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood [Phase 1, Phase 2]
Phase 1/2 trial evaluating Wilms' Tumor 1 protein vaccine for blood cancers has completed. Results were posted on 2014-05-08.
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors [Phase 1]
Phase 1 pilot study evaluating donor-derived natural killer cell infusions for refractory non-B lineage hematologic cancers and solid tumors…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome [Phase 2]
A Phase 2 trial (SIMIDIS) evaluating azacitidine in combination with beta-erythropoietin for myelodysplastic syndrome has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors [Phase 2]
Phase 2 trial results evaluate a bortezomib-based graft-versus-host disease prophylaxis strategy after allogeneic transplantation in patient…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: Clofarabine in High Risk Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]
A Phase 1/2 clinical trial of clofarabine for high-risk myelodysplastic syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD) [Phase 2]
Phase 2 trial update on thymoglobulin, sirolimus, and mycophenolate mofetil for preventing acute GVHD in hematologic malignancies; study ter…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: PRO#0118: Decitabine Plus Mini Flu-Bu [Phase 1]
A Phase 1 trial evaluating decitabine with a mini Flu-Bu conditioning regimen for acute myeloid leukemia and myelodysplastic syndrome has co…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Ondansetron Versus Aprepitant Plus Ondansetron for Emesis [Phase 2]
Phase 2 trial comparing ondansetron alone versus aprepitant plus ondansetron for prevention of emesis in patients with hematologic diseases,…
-
CLINICAL_TRIALS trial_result · 2014-01-01Clinical Trial Update: A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation [Phase 1]
A Phase 1 pediatric study evaluating a plerixafor-containing regimen as part of a second allogeneic stem cell transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating an unrelated cord blood transplant plus a haplo-identical, T-cell depleted stem cell transplant from a r…
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS [Phase 3]
A Phase 3 randomized trial comparing Procrit (epoetin alfa) versus no Procrit in patients with acute myeloid leukemia and high-risk myelodys…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome [Phase 3]
A Phase 3 study evaluating the effectiveness and safety of decitabine in patients with myelodysplastic syndrome has completed and posted res…
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: A Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic Syndrome [Phase 1]
Phase 1 study of JNJ-30979754 (decitabine) in patients with myelodysplastic syndrome has completed, with results posted in December 2013.
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial results evaluate the combination of fludarabine and cytarabine in patients with acute myeloid leukemia and high-risk myelodysp…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Intraosseous Infusion of Unrelated Cord Blood Grafts [NA]
Clinical trial evaluating intraosseous infusion of unrelated cord blood grafts was terminated; sponsor was Emory University, and it studied …
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome [Phase 2]
Phase 2 study of Telintra in non-Del(5q) myelodysplastic syndrome has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation [Phase 1, Phase 2]
This clinical trial update covers ASC-101 in patients with hematologic malignancies undergoing dual-cord umbilical cord blood transplantatio…
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study [Phase 4]
A Phase 4 GI tolerability study of deferasirox in patients with myelodysplastic syndrome and transfusional iron overload conducted by Novart…
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) [Phase 2]
Phase 2 clinical trial evaluating azacitidine in transfusion-dependent patients with low-risk myelodysplastic syndrome or chronic myelomonoc…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function [Phase 1]
Phase 1 pharmacokinetics and safety study of azacitidine in cancer patients with and without impaired renal function has completed. Results …
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Erlotinib Study for Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 clinical trial of Erlotinib for Myelodysplastic Syndrome has completed; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS) [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of decitabine in participants with myelodysplastic syndrome has completed and results wer…
-
CLINICAL_TRIALS trial_result · 2013-08-14Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer [Phase 1]
A Phase 1 trial evaluating donor umbilical cord blood transplant for patients with advanced hematologic cancers.